PHILADELPHIA, PA – November 20, 2015 – Janney Montgomery Scott LLC, a full-service financial services, wealth management and capital markets firm employing over 1,800 employees across 100 locations, announced today the hiring of a new senior research analyst, Debjit Chattopadhyay, Ph.D., who will be covering the Biotechnology sector based out of Janney’s Philadelphia headquarters. Debjit’s coverage will be primarily focused on gene therapy, anti-infectives, oncology, and rare disease.
Mr. Chattopadhyay covers the biotechnology space from the Philadelphia office. Prior to joining Janney, he was a senior biotechnology analyst at ROTH Capital Partners, where he expanded the healthcare franchise and focused on gene therapy, immuno-oncology and rare diseases.
Market Data 
Markets 
AI
